跳至主要内容
临床试验/NCT02051790
NCT02051790已完成4 期

Evaluation of Reader Training Processes by Comparing Clinical Interpretations to Centralized Expert Reads

Avid Radiopharmaceuticals1 个研究点 分布在 1 个国家目标入组 241 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
241
试验地点
1
主要终点
Agreement Between Expert Panel and Clinical Practice Reads

研究概览

简要总结

This study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Scan obtained for clinical reasons

排除标准

  • 未提供

研究组 & 干预措施

Clinical Practice Scans

Experimental

Approximately 250 florbetapir F 18 scans and final scan reports interpreted in a clinical setting will be collected from physicians across the country. These results will then be compared to expert panel interpretations for the same scans.

干预措施: florbetapir F 18 (Drug)

结局指标

主要结局

Agreement Between Expert Panel and Clinical Practice Reads

时间窗: Scan acquired 50-60 minutes post injection

Agreement between expert panel consensus scan interpretations and clinical practice reader scan interpretations was calculated as a weighted Kappa value across all cases and all clinical practice readers.

次要结局

未报告次要终点

研究者

发起方
Avid Radiopharmaceuticals
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验